In Brief: NeoPath v. Neuromedical Systems Inc.
This article was originally published in The Gray Sheet
NeoPath v. Neuromedical Systems Inc.: NeoPath files suit March 28 in the U.S. District Court for the Western District of Washington in Seattle alleging that Neuromedical's Papnet automated cervical cytology reader system infringes three NeoPath patents covering technology utilized in its AutoPap 300 QC Pap smear slide quality control rescreening system. The suit requests that the court grant "preliminary and final injunctions enjoining" Neuromedical and its subsidiaries from further infringement and "award damages in the amount of lost profits for the infringement of" the three patents. Neuromedical plans to contest the suit. A separate suit filed in July by Neuromedical Systems against NeoPath makes several allegations, including patent infringement, false advertising and unfair competition ("The Gray Sheet" July 22, 1996, In Brief)...
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.